Protein,Protein_definition,Disease_category,Disease,method,nsnp,OR [95% CI],Pvalue,QTL_type
HBEGF,Proheparin-binding EGF-like growth factor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_AGRANULOCYTOSIS,Inverse variance weighted,22,0.78 [0.62-0.97],0.0259250858028998,trans
HBEGF,Proheparin-binding EGF-like growth factor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_PURPURA_AND3_OTHER_HAEMORRHAGIC,Inverse variance weighted,22,0.86 [0.71-1.06],0.155835372015107,trans
HBEGF,Proheparin-binding EGF-like growth factor,Chapter IX Diseases of the circulatory system,I9_CORATHER,Inverse variance weighted,22,0.95 [0.89-1.02],0.200141685083483,trans
HBEGF,Proheparin-binding EGF-like growth factor,Chapter IX Diseases of the circulatory system,I9_IHD,Inverse variance weighted,22,0.97 [0.91-1.04],0.40340544122126,trans
HBEGF,Proheparin-binding EGF-like growth factor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_THROMBOCYTOPENIANAS,Inverse variance weighted,22,0.92 [0.69-1.24],0.592022308402536,trans
HBEGF,Proheparin-binding EGF-like growth factor,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,Inverse variance weighted,22,1.01 [0.92-1.1],0.876284081050135,trans
